Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the "Real World"

Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the "Real World" book cover

Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the "Real World"

Author(s): Michael S Ritsner

  • Publisher: Springer
  • Publication Date: February 20, 2013
  • Language: English
  • Print length: 340 pages
  • ISBN-10: 9400758006
  • ISBN-13: 9789400758001

Book Description

About the Editor

Preface

Contributors to Volume II

Part 1. Antipsychotic polypharmacy

1. Antipsychotic polypharmacy for schizophrenia: ‘Secret sauce’ or ‘wild abandon’? Peter F. Buckley

2. Antipsychotic polypharmacy in USA. Anand K. Pandurangi, John Vernon

3. Antipsychotic polypharmacy in Czech Republic and in Ukraine. Viktor P. Samokhvalov, Oxana Samokhvalova, Viktoria A. Verbenko, Georgij N. Verbenko

4. Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice. Lucio Ghio, Werner Natta, Simona Gotelli, Luigi Ferrannini

5. Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational? KH Yong, Norman Sartorius, Kang Sim

6. Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice? Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Masaru Mimura

7. Clozapine combinations in treatment-resistant schizophrenia patients. Vladimir Lerner and Chanoch Miodownik

8. Metabolic syndrome and antipsychotic polypharmacy. Fuminari Misawa, Fujii Yasuo, Yasuyuki Okumura, Hiroto Ito

Part 2. Polypharmacy for other psychiatric conditions

9. Evidence based combination therapy for bipolar disorder. Stamatia Magiria, Melina Siamouli, Xenia Gonda, Apostolos Iacovides, Konstantinos N. Fountoulakis

10. Antidepressant combination strategies for major depressive disorder. André F. Carvalho, Danielle S. Macêdo, Thomas N. Hyphantis, Roger S. McIntyre

11. Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk. Arun V. Ravindran and Tricia L. da Silva

12. Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy? Frederike Schirmbeck and Mathias Zink

13. Polypharmacy and potentially inappropriate medication use among elders with dementia. Jan Lužný

14. The role of polypharmacy in bipolar disorder treatment guidelines. Heinz Grunze

Appendix Rena Kurs

1. Annotated bibliography on polypharmacy

2. List of Psychotropic Medications

Contents to Volume I

Contributors to Volume I

Index

View on Amazon

未经允许不得转载:Wow! eBook » Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the "Real World"